ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2019 American Transplant Congress

    Bcl-2/Bcl-xL Inhibition by Navitoclax vs. Bcl-2 Alone Inhibition by Venetoclax for Induction of Mixed Chimerism in Non-Human Primates

    H. Sasaki1, D. Ma1, T. Oura1, A. Dehnadi1, I. Rosales2, B. Cosimi1, P. Cippa3, T. Fehr3, T. Kawai1

    1Surgery, Massachusetts General Hospital, Boston, MA, 2Pathology, Massachusetts General Hospital, Boston, MA, 3Medicine, University of Zurich, Zurich, Switzerland

    *Purpose: We recently demonstrated that a specific Bcl-2 inhibitor, Venetoclax, can promote mixed chimerism and renal allograft tolerance in non-human primates (NHPs) with reduced myelosuppressive…
  • 2019 American Transplant Congress

    Mortality and Morbidity in Kidney Transplant Recipients with a Failing Graft

    N. N. Lam1, D. J. Boyne2, R. R. Quinn2, P. C. Austin3, B. R. Hemmelgarn2, P. Campbell1, G. A. Knoll4, L. Tibbles2, S. Yilmaz2, H. Quan2, P. Ravani2

    1University of Alberta, Edmonton, AB, Canada, 2University of Calgary, Calgary, AB, Canada, 3ICES, Toronto, ON, Canada, 4University of Ottawa, Ottawa, ON, Canada

    *Purpose: Due to their history of renal disease and exposure to immunosuppression, kidney transplant recipients with a failing graft may be at higher risk of…
  • 2019 American Transplant Congress

    Safety and Efficacy of Imlifidase in Highly-Sensitized Kidney Transplant Patients: Results from a Phase 2 Study

    S. C. Jordan1, C. Legendre2, N. Desai3, T. Lorant4, M. Bengtsson4, L. Laxmyr5, B. Lonze6, A. Vo1, K. J. Wood7, C. Kjellman5, R. A. Montgomery6

    1Cedars-Sinai Medical Center, Los Angeles, CA, 2Hopital Necker, Paris, France, 3Johns Hopkins University, Baltimore, MD, 4Uppsala University, Uppsala, Sweden, 5Hansa Medical AB, Lund, Sweden, 6NYU Langone Health Transplant Institute, New York, NY, 7University of Oxford, Oxford, United Kingdom

    *Purpose: Many patients eligible for kidney transplantation are sensitized to allo-HLA antigens and face prolonged waiting times and increased mortality. The presence of donor specific…
  • 2019 American Transplant Congress

    Tolerance Induction with Hematopoietic Stem Cells in Kidney Transplantations

    K. Lee, J. Park, Y. Chung, S. Kim

    Department of Surgery, Samsung Medical Center, Seoul, Korea, Republic of

    *Purpose: Tolerance induction is considered to be the final goal in the field of organ transplantation. We have performed combined bone marrow and kidney transplantation…
  • 2019 American Transplant Congress

    Lifestyle Intervention in Renal Transplant Recipients: A Multicenter, Randomized Clinical Trial

    E. Corpeleijn1, G. Klaassen2, D. M. Zelle2, D. Dijkema3, I. van Vliet2, F. J. Bemelman4, G. J. Navis2, S. J. Bakker2

    1Department of Epidemiology, University Medical Center Groningen, Groningen, Netherlands, 2Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands, 3Department of Dietetics, University Medical Center Groningen, Groningen, Netherlands, 4Department of Nephrology, Amsterdam Medical Center, Amsterdam, Netherlands

    *Purpose: Low physical activity and reduced physical functioning are common after renal transplantation, resulting in a reduced quality of life. The aim of this study…
  • 2019 American Transplant Congress

    Autoantibody Production Significantly Decreased with APRIL/BLyS Blockade in Murine Chronic Rejection Kidney Transplant Model

    N. Bath, X. Ding, B. Verhoven, S. Reese, N. Wilson, A. Sukhwal, R. Redfield III

    University of Wisconsin, Madison, WI

    *Purpose: Chronic antibody mediated rejection (cAMR) remains a significant barrier to achieving long-term graft survival in kidney transplantation. Alloantibody production from B lymphocytes and plasma…
  • 2019 American Transplant Congress

    Machine Perfusion Allows Use of High KDPI and Prolonged Cold Ischemia Time in Deceased Donors: A Single Center Effort to Decrease Discard Rates

    M. Ortigosa-Goggins, J. Gaynor, A. Mattiazzi, J. Figueiro, G. Burke, G. Ciancio, G. Guerra

    Miami Transplant Institute, University of Miami, Miami, FL

    *Purpose: Discard rates of deceased donor kidney transplants(DDKT)rises as the kidney donor profile index(KDPI)increases,and approaches 60%for KDPI of >85%.Pulsatile machine perfusion(MP)allows use of kidneys with…
  • 2019 American Transplant Congress

    The Collaborative Improvement and Innovation Network (COIIN): Impact on Deceased Donor Transplant Rates and Offer Acceptance Practices

    A. Wey1, S. Gustafson1, B. Carrico2, J. Foutz2, K. Sisaithong3, M. McBride2, D. Klassen2, D. Klassen2, N. Salkowski1, B. Kasiske1, A. Israni1, J. Snyder1

    1SRTR, Minneapolis, MN, 2OPTN, Richmond, VA, 3OPTN, Minneapolis, MN

    *Purpose: The Organ Procurement and Transplantation Network (OPTN) completed the Collaborative Improvement and Innovation Network (COIIN), a study to increase kidney transplants by reducing risk…
  • 2019 American Transplant Congress

    Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection

    D. Kumar1, M. Raynaud2, P. Halloran3, A. Loupy2, J. Chang3, J. Reeve3, I. Yakubu1, S. Bobba1, L. Kamal1, M. Levy1, C. Bhati1, P. Kimball1, A. King1, G. Gupta1

    1Virginia Commonwealth University, Richmond, VA, 2Paris Transplant Group, Paris, France, 3Alberta Transplant Genomics Applied Centre, Edmonton, AB, Canada

    *Purpose: Chronic active antibody mediated rejection (cABMR) is a major cause of long-term kidney transplant (KT) loss. Current therapies have unclear efficacy and significant side…
  • 2019 American Transplant Congress

    High Numbers of Differentiated CD8+CD28– T Cells Are Associated with a Substantially Lowered Risk for Late Rejection and Graft Loss after Kidney Transplantation

    M. G. Betjes, A. Langerak, M. Klepper, N. Litjens

    Nephrology & Transplantation, Erasmus MC, Rotterdam, Netherlands

    *Purpose: Recipients of a kidney transplant have a prematurely aged T-cell system. This is reflected in lowered thymic output, reduced telomere length and more highly…
  • « Previous Page
  • 1
  • …
  • 244
  • 245
  • 246
  • 247
  • 248
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences